Craft

3sbio

Stock Price

$6.8

2023-09-27

Market Capitalization

$16.2 B

2023-09-27

Revenue

¥6.9 B

FY, 2022

3sbio Summary

Company Summary

Overview
3sbio (三生制药集团) is a company that develops biopharmaceuticals. Its product lineup covers several treatment fields including cancer, autoimmune, kidney disease, metabolism, and dermatology.
Type
Public
Status
Active
Founded
1993
HQ
Shenyang, CN | view all locations
Website
http://www.3sbio.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Shenyang, Liaoning HQ

    China

    No. 1A 3, No. 10 Road

3sbio Financials

Summary Financials

Revenue (FY, 2022)
¥6.9B
Gross profit (FY, 2022)
¥6.1B
Net income (FY, 2022)
¥1.9B
Cash (FY, 2022)
¥2.1B
EBIT (FY, 2022)
¥1.8B
Enterprise value
$18.6B

Footer menu